Kristen Scarpato, MD, MPH

David Ambinder, MD

GU Oncology Now

At an American Urological Association plenary session, a panel of experts debated salvage therapy options after RT failure for a patient with biochemically recurrent (BCR) prostate cancer. The panel weighed the pros and cons of surgery, cryotherapy, high intensity focused ultrasound, and ADT/observation.David Ambinder, MD, New York Medical College/Westchester Medical Center, interviewed panelist Kristen Scarpato, MD, MPH, Vanderbilt University Medical Center, on when focal therapy and other treatment options should be recommended in this patient population.View more&nbsp;<a href="https://guoncologynow.com/conference/aua-2023" target="_blank" rel="noopener">AUA 2023 meeting</a>&nbsp;coverage.

Drs. Kristen Scarpato, David Ambinder Discuss Salvage Therapy Options for BCR Prostate Cancer

AUA 2023

Dr. Ambinder interviews Dr. Scarpato on when focal therapy should be recommended as salvage therapy for patients with biochemically recurrent prostate cancer.

Drs. Scarpato Ambinder Discuss Salvage Therapy for BCR PC

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Prostate Cancer

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe